{"id":"https://openalex.org/W7225016205","doi":"https://doi.org/10.1007/s00520-026-11393-4","title":"Managing trastuzumab deruxtecan-related adverse events in patients with metastatic breast cancer: insights from a worldwide survey of the Hermione EDUcational project","display_name":"Managing trastuzumab deruxtecan-related adverse events in patients with metastatic breast cancer: insights from a worldwide survey of the Hermione EDUcational project","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7225016205","doi":"https://doi.org/10.1007/s00520-026-11393-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/42965705","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13723672"},"language":"en","primary_location":{"id":"doi:10.1007/s00520-026-11393-4","doi":"https://doi.org/10.1007/s00520-026-11393-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00520-026-11393-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00520-026-11393-4.pdf","source":{"id":"https://openalex.org/S50055314","display_name":"Supportive Care in Cancer","issn_l":"0941-4355","issn":["0941-4355","1433-7339"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Supportive Care in Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00520-026-11393-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041668420","display_name":"Marina Elena Cazzaniga","orcid":"https://orcid.org/0000-0003-1756-6935","observed_orcids":["https://orcid.org/0000-0003-1756-6935"]},"institutions":[{"id":"https://openalex.org/I66752286","display_name":"University of Milano-Bicocca","ror":"https://ror.org/01ynf4891","country_code":"IT","type":"education","lineage":["https://openalex.org/I66752286"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Marina Elena Cazzaniga","raw_affiliation_strings":["Phase 1 Research Centre, Fondazione IRCCS San Gerardo Dei Tintori, Monza, MB, Italy. marinaelena.cazzaniga@irccs-sangerardo.it","School of Medicine and Surgery, University of Milano-Bicocca, Monza, MB, Italy. marinaelena.cazzaniga@irccs-sangerardo.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase 1 Research Centre, Fondazione IRCCS San Gerardo Dei Tintori, Monza, MB, Italy. marinaelena.cazzaniga@irccs-sangerardo.it","institution_ids":[]},{"raw_affiliation_string":"School of Medicine and Surgery, University of Milano-Bicocca, Monza, MB, Italy. marinaelena.cazzaniga@irccs-sangerardo.it","institution_ids":["https://openalex.org/I66752286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033285318","display_name":"Matti Aapro","orcid":"https://orcid.org/0000-0003-3570-8319","observed_orcids":["https://orcid.org/0000-0003-3570-8319"]},"institutions":[{"id":"https://openalex.org/I4210105860","display_name":"Clinique de Genolier","ror":"https://ror.org/01neevw97","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210105860"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matti Aapro","raw_affiliation_strings":["Genolier Cancer Center, Clinique de Genolier, Genolier, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genolier Cancer Center, Clinique de Genolier, Genolier, Switzerland","institution_ids":["https://openalex.org/I4210105860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112893222","display_name":"Manuel Alva Bianchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086614","display_name":"Research Institute Hospital 12 de Octubre","ror":"https://ror.org/002x1sg85","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210086614"]},{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Alva Bianchi","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain","Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (Imas12), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]},{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (Imas12), Madrid, Spain","institution_ids":["https://openalex.org/I4210086614","https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055348459","display_name":"Andreas Charalambous","orcid":"https://orcid.org/0000-0003-4050-031X","observed_orcids":["https://orcid.org/0000-0003-4050-031X"]},"institutions":[{"id":"https://openalex.org/I163151358","display_name":"Cyprus University of Technology","ror":"https://ror.org/05qt8tf94","country_code":"CY","type":"education","lineage":["https://openalex.org/I163151358"]}],"countries":["CY"],"is_corresponding":false,"raw_author_name":"Andreas Charalambous","raw_affiliation_strings":["Department of Nursing, Cyprus University of Technology, Limassol, Cyprus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nursing, Cyprus University of Technology, Limassol, Cyprus","institution_ids":["https://openalex.org/I163151358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058796036","display_name":"Laura Cortesi","orcid":"https://orcid.org/0000-0001-8950-8561","observed_orcids":["https://orcid.org/0000-0001-8950-8561"]},"institutions":[{"id":"https://openalex.org/I122346577","display_name":"University of Modena and Reggio Emilia","ror":"https://ror.org/02d4c4y02","country_code":"IT","type":"education","lineage":["https://openalex.org/I122346577"]},{"id":"https://openalex.org/I4210090508","display_name":"Azienda Sanitaria Unit\u00e0 Locale di Reggio Emilia","ror":"https://ror.org/001bbwj30","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210090508"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Cortesi","raw_affiliation_strings":["Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy","Medical Oncology, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy","institution_ids":["https://openalex.org/I122346577"]},{"raw_affiliation_string":"Medical Oncology, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy","institution_ids":["https://openalex.org/I4210090508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109328330","display_name":"Luis Costa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I4405252639","display_name":"Gulbenkian Institute for Molecular Medicine","ror":"https://ror.org/0346k0491","country_code":"PT","type":"nonprofit","lineage":["https://openalex.org/I4405252639"]},{"id":"https://openalex.org/I4405255475","display_name":"Unidade Local de Sa\u00fade Santa Maria","ror":"https://ror.org/031xaae12","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405255475"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Luis Costa","raw_affiliation_strings":["Faculty of Medicine, University of Lisbon, Lisbon, Portugal","Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal","Medical Oncology Department, Unidade Local de Sa\u00fade Santa Maria, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, University of Lisbon, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103"]},{"raw_affiliation_string":"Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal","institution_ids":["https://openalex.org/I4405252639"]},{"raw_affiliation_string":"Medical Oncology Department, Unidade Local de Sa\u00fade Santa Maria, Lisbon, Portugal","institution_ids":["https://openalex.org/I4405255475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160247505","display_name":"Peter Fashing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]},{"id":"https://openalex.org/I4210149747","display_name":"Comprehensive Cancer Center Erlangen","ror":"https://ror.org/05jfz9645","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210149747"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Fashing","raw_affiliation_strings":["University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Department of Gynecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Department of Gynecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053","https://openalex.org/I4210149747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121238753","display_name":"Ana Bel\u00e9n Rodr\u00edguez Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Belen Rodriguez Garcia","raw_affiliation_strings":["Department of Radiation Oncology, Hospital Clinic de Barcelona, Barcelona, Spain","Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Hospital Clinic de Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097"]},{"raw_affiliation_string":"Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085758096","display_name":"Gilles Freyer","orcid":"https://orcid.org/0000-0001-6001-164X","observed_orcids":["https://orcid.org/0000-0001-6001-164X"]},"institutions":[{"id":"https://openalex.org/I203339264","display_name":"Universit\u00e9 de Lyon","ror":"https://ror.org/01rk35k63","country_code":"FR","type":"education","lineage":["https://openalex.org/I203339264"]},{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Freyer Gilles","raw_affiliation_strings":["Department of Medical Oncology, Lyon University Hospital, HCL, Lyon, France","Universit\u00e9 de Lyon, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Lyon University Hospital, HCL, Lyon, France","institution_ids":["https://openalex.org/I4210100596"]},{"raw_affiliation_string":"Universit\u00e9 de Lyon, Lyon, France","institution_ids":["https://openalex.org/I203339264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035133541","display_name":"Bryan Hennessy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142762351","display_name":"Royal College of Surgeons in Ireland","ror":"https://ror.org/01hxy9878","country_code":"IE","type":"education","lineage":["https://openalex.org/I142762351"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Bryan Hennessy","raw_affiliation_strings":["Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland","institution_ids":["https://openalex.org/I142762351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045525779","display_name":"Hirotoshi Iihara","orcid":"https://orcid.org/0000-0002-4171-454X","observed_orcids":["https://orcid.org/0000-0002-4171-454X"]},"institutions":[{"id":"https://openalex.org/I4210105815","display_name":"Gifu University Hospital","ror":"https://ror.org/01kqdxr19","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105815"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirotoshi Iihara","raw_affiliation_strings":["Cancer Center, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan","Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan","institution_ids":["https://openalex.org/I4210105815"]},{"raw_affiliation_string":"Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan","institution_ids":["https://openalex.org/I4210105815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039020134","display_name":"Maria Lapuente","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maria Lapuente","raw_affiliation_strings":["Bartholomew's Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bartholomew's Hospital, London, UK","institution_ids":["https://openalex.org/I1307195382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008584660","display_name":"Fei Ma","orcid":"https://orcid.org/0000-0001-9432-1902","observed_orcids":["https://orcid.org/0000-0001-9432-1902","https://orcid.org/0000-0003-0652-4801"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210141458","display_name":"Cancer Hospital of Chinese Academy of Medical Sciences","ror":"https://ror.org/03x937183","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141458"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fei Ma","raw_affiliation_strings":["National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210141458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160262003","display_name":"Irati Rodriguez Matesanz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irati Rodriguez Matesanz","raw_affiliation_strings":["City of Hope, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Atlanta, GA, USA","institution_ids":["https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062438676","display_name":"Kelly Elizabeth McCann","orcid":"https://orcid.org/0000-0001-8233-6242","observed_orcids":["https://orcid.org/0000-0001-8233-6242"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Elizabeth McCann","raw_affiliation_strings":["Department of Medicine, Division of Hematology Oncology, University of California San Diego, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology Oncology, University of California San Diego, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101445353","display_name":"Yeon Hee Park","orcid":"https://orcid.org/0000-0003-4156-9212","observed_orcids":["https://orcid.org/0000-0003-4156-9212"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Yeon Hee Park","raw_affiliation_strings":["Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090188675","display_name":"Hope S. Rugo","orcid":"https://orcid.org/0000-0001-6710-4814","observed_orcids":["https://orcid.org/0000-0001-6710-4814"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hope S. Rugo","raw_affiliation_strings":["Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110115990","display_name":"Hitomi Sakai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119182057","display_name":"SHOWA Medical University","ror":"https://ror.org/04mzk4q39","country_code":"JP","type":"education","lineage":["https://openalex.org/I119182057"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitomi Sakai","raw_affiliation_strings":["Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan","institution_ids":["https://openalex.org/I119182057"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109048545","display_name":"Florian Strasser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Florian Strasser","raw_affiliation_strings":["Cancer Fatigue Clinic (Schaffhausen, M\u00fcnsterlingen, Sargans), St. Gallen, Switzerland","Hoch Health Ostschweiz St. Gallen, St. Gallen, Switzerland","University of Bern, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Fatigue Clinic (Schaffhausen, M\u00fcnsterlingen, Sargans), St. Gallen, Switzerland","institution_ids":[]},{"raw_affiliation_string":"Hoch Health Ostschweiz St. Gallen, St. Gallen, Switzerland","institution_ids":[]},{"raw_affiliation_string":"University of Bern, Bern, Switzerland","institution_ids":["https://openalex.org/I118564535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054534032","display_name":"Benjam\u00edn Walbaum","orcid":"https://orcid.org/0000-0003-2314-5360","observed_orcids":["https://orcid.org/0000-0003-2314-5360"]},"institutions":[{"id":"https://openalex.org/I162148367","display_name":"Pontificia Universidad Cat\u00f3lica de Chile","ror":"https://ror.org/04teye511","country_code":"CL","type":"education","lineage":["https://openalex.org/I162148367"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["CL","ES"],"is_corresponding":false,"raw_author_name":"Benjamin Walbaum","raw_affiliation_strings":["Department of Hematology Oncology, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile","Facultat de Medicina I Ciencias de La Salut, Universitat de Barcelona (UB), Barcelona, Spain","Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology Oncology, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile","institution_ids":["https://openalex.org/I162148367"]},{"raw_affiliation_string":"Facultat de Medicina I Ciencias de La Salut, Universitat de Barcelona (UB), Barcelona, Spain","institution_ids":["https://openalex.org/I71999127"]},{"raw_affiliation_string":"Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160253844","display_name":"Shusen Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157773358","display_name":"Sun Yat-sen University","ror":"https://ror.org/0064kty71","country_code":"CN","type":"education","lineage":["https://openalex.org/I157773358"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shusen Wang","raw_affiliation_strings":["Sun Yat-Sen University, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sun Yat-Sen University, Guangzhou, China","institution_ids":["https://openalex.org/I157773358"]}]}],"institutions":[],"countries_distinct_count":14,"institutions_distinct_count":32,"corresponding_author_ids":["https://openalex.org/A5041668420"],"corresponding_institution_ids":["https://openalex.org/I66752286"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82576967,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"11","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8422999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8422999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.03629999980330467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.02590000070631504,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":1.0},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8389999866485596},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9190000295639038},{"id":"https://openalex.org/keywords/her2-low-breast-cancer","display_name":"HER2-low breast cancer","score":0.7239999771118164},{"id":"https://openalex.org/keywords/adverse-event-management","display_name":"adverse event management","score":0.6949999928474426},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.8880000114440918},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.9670000076293945},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.9580000042915344},{"id":"https://openalex.org/keywords/nk1-receptor-antagonists","display_name":"NK1 receptor antagonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.9110000133514404},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9679999947547913},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.7059999704360962},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.957099974155426},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6550999879837036},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6128000020980835},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.5673999786376953},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5663999915122986},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5616000294685364},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5615000128746033},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4666000008583069},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4399000108242035},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4262000024318695},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4187999963760376},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3935000002384186},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.3677999973297119},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36079999804496765},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.351500004529953},{"id":"https://openalex.org/C2991975920","wikidata":"https://www.wikidata.org/wiki/Q621261","display_name":"Pain medicine","level":3,"score":0.30880001187324524},{"id":"https://openalex.org/C518773536","wikidata":"https://www.wikidata.org/wiki/Q918533","display_name":"Nursing research","level":2,"score":0.30390000343322754},{"id":"https://openalex.org/C2777929519","wikidata":"https://www.wikidata.org/wiki/Q7144988","display_name":"Patient education","level":2,"score":0.2806999981403351},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2752000093460083},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.2696000039577484},{"id":"https://openalex.org/C22467394","wikidata":"https://www.wikidata.org/wiki/Q849359","display_name":"Multidisciplinary approach","level":2,"score":0.2615000009536743},{"id":"https://openalex.org/C2776035688","wikidata":"https://www.wikidata.org/wiki/Q1606558","display_name":"Affect (linguistics)","level":2,"score":0.25279998779296875},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.25220000743865967}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D017563","descriptor_name":"Lung Diseases, Interstitial","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D064729","descriptor_name":"Neurokinin-1 Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s00520-026-11393-4","doi":"https://doi.org/10.1007/s00520-026-11393-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00520-026-11393-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00520-026-11393-4.pdf","source":{"id":"https://openalex.org/S50055314","display_name":"Supportive Care in Cancer","issn_l":"0941-4355","issn":["0941-4355","1433-7339"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Supportive Care in Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13723672","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13723672/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13723672/pdf/520_2026_Article_11393.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Support Care Cancer","raw_type":"Text"},{"id":"pmid:42965705","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42965705","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","raw_type":"Journal Article"},{"id":"doi:10.48620/102136","doi":"https://doi.org/10.48620/102136","is_oa":true,"landing_page_url":"https://doi.org/10.48620/102136","pdf_url":null,"source":{"id":"https://openalex.org/S7407053152","display_name":"Open Access CRIS of the University of Bern","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1007/s00520-026-11393-4","doi":"https://doi.org/10.1007/s00520-026-11393-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00520-026-11393-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00520-026-11393-4.pdf","source":{"id":"https://openalex.org/S50055314","display_name":"Supportive Care in Cancer","issn_l":"0941-4355","issn":["0941-4355","1433-7339"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Supportive Care in Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320310276","display_name":"Helsinn","ror":"https://ror.org/01kdzkq48"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225016205.pdf","grobid_xml":"https://content.openalex.org/works/W7225016205.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W2387397851","https://openalex.org/W4220964921","https://openalex.org/W4281640394","https://openalex.org/W4366529414","https://openalex.org/W4376598179","https://openalex.org/W4377087871","https://openalex.org/W4388928404","https://openalex.org/W4390776701","https://openalex.org/W4392653246","https://openalex.org/W4393359012","https://openalex.org/W4396213256","https://openalex.org/W4396827186","https://openalex.org/W4402541250","https://openalex.org/W4402548585","https://openalex.org/W4405732807","https://openalex.org/W4410312427","https://openalex.org/W4410415109","https://openalex.org/W4412613439","https://openalex.org/W4413741200","https://openalex.org/W4415681359","https://openalex.org/W7129756687"],"related_works":["https://openalex.org/W4412613439","https://openalex.org/W4281908586","https://openalex.org/W4392653246","https://openalex.org/W4290993146","https://openalex.org/W4401323709","https://openalex.org/W4385659305","https://openalex.org/W4416987515","https://openalex.org/W4387807591","https://openalex.org/W4393098912","https://openalex.org/W7129616711"],"abstract_inverted_index":{"PURPOSE:":[0],"Trastuzumab":[1],"deruxtecan":[2],"(T-DXd)":[3],"has":[4],"shown":[5],"remarkable":[6],"efficacy":[7],"in":[8,12,47,54,77,158,190],"phase":[9],"III":[10],"trials":[11],"patients":[13,152,174,181,242],"with":[14,131,153,186,248],"HER2-positive":[15],"early-":[16],"and":[17,21,31,62,81,91,102,133,148,168,196,200,209,220,235,245],"late-stage":[18],"breast":[19,24],"cancer":[20,25],"HER2-low/ultra-low":[22],"metastatic":[23],"(mBC).":[26],"However,":[27],"toxicities":[28,232],"remain":[29],"prevalent":[30],"clinically":[32],"relevant,":[33],"leading":[34],"to":[35,51,150,202],"dose":[36],"reductions/interruptions":[37],"or":[38,204,218],"discontinuation.":[39],"METHODS:":[40],"A":[41],"survey":[42],"was":[43,214,221],"conducted":[44],"across":[45],"oncologists":[46],"13":[48],"countries":[49],"worldwide":[50],"collect":[52],"experiences":[53],"managing":[55],"T-DXd-related":[56,231],"toxicities,":[57,87],"focusing":[58],"on":[59],"nausea/vomiting,":[60],"fatigue,":[61,185],"interstitial":[63],"lung":[64],"disease":[65],"(ILD)":[66],"as":[67,216],"key":[68],"areas":[69],"of":[70,93,112,114,139,194,211,230,241],"clinical":[71],"concern.":[72],"RESULTS:":[73],"Ninety-nine":[74],"experts":[75],"participated":[76],"the":[78,84,159],"survey.":[79],"Nausea":[80],"fatigue":[82,201],"were":[83,104],"most":[85,197],"common":[86],"reported":[88,215],"by":[89],"91.9%":[90],"94.9%":[92],"respondents,":[94,180],"respectively.":[95],"5-HT3":[96],"receptor":[97,100,117,128,135,146],"antagonists,":[98,101],"NK1":[99,127,145],"corticosteroids":[103,132],"\"very":[105],"often\"":[106],"prescribed":[107,141],"for":[108,165,172],"prophylaxis.":[109],"The":[110],"frequency":[111],"use":[113],"second\u2011generation":[115],"5\u2011HT3":[116,134],"antagonists":[118,147],"varied":[119],"among":[120],"respondents.":[121],"Most":[122],"frequently,":[123],"they":[124],"employed":[125],"an":[126,237],"antagonist":[129],"combined":[130],"antagonists.":[136],"Forty-four":[137],"percent":[138],"respondents":[140],"4\u2011drug":[142],"regimens":[143],"incorporating":[144],"olanzapine":[149],"all":[151,173,179],"nausea/vomiting":[154,199],"above":[155],"grade":[156],"1":[157],"first":[160],"cycle,":[161],"35%":[162],"reserved":[163],"them":[164,171],"high\u2011risk":[166],"patients,":[167,195],"21%":[169],"used":[170],"from":[175],"cycle":[176],"one.":[177],"For":[178],"receiving":[182],"T\u2011DXd":[183],"experienced":[184],"65%":[187],"observing":[188],"it":[189],"more":[191],"than":[192],"60%":[193],"considered":[198],"moderately":[203],"significantly":[205],"affect":[206],"daily":[207],"activities":[208],"quality":[210],"life.":[212],"ILD":[213],"rare":[217],"occasional":[219],"generally":[222],"monitored":[223],"using":[224],"computed":[225],"tomography.":[226],"CONCLUSION:":[227],"Real-life":[228],"management":[229],"is":[233],"complex":[234],"needs":[236],"ongoing":[238],"comprehensive":[239],"evaluation":[240],"before,":[243],"during":[244],"after":[246],"therapy,":[247],"a":[249],"highly":[250],"trained/skilled":[251],"multidisciplinary":[252],"team.":[253]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-01T00:00:00"}